Robert W. Baird analyst Michael Polark maintained a Hold rating on Irhythm Technologies (NASDAQ:IRTC) on Friday, setting a price target of $80, which is approximately 10.69% below the present share price of $89.58.
Polark expects Irhythm Technologies to post earnings per share (EPS) of -$0.33 for the second quarter of 2021.
The current consensus among 11 TipRanks analysts is for a Moderate Buy rating of shares in Irhythm Technologies, with an average price target of $97.8.
The analysts price targets range from a high of $115 to a low of $80.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $78.81 million and a net profit of -$9.58 million. The company's market cap is $2.61 billion.
According to TipRanks.com, Robert W. Baird analyst Michael Polark is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 14.1% and a 75.00% success rate.
iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.